Neuro-Oncology: The Podcast

108 Episoade

1. Pre-operative [11C]methionine PET for low-grade glioma

   Publicat: 16.12.2022
2. The role of T lymphocytes in the glioma pathobiology

   Publicat: 02.12.2022
3. CDKN2A homozygous deletion in IDH mutant astrocytoma

   Publicat: 08.10.2022
4. EGFR: the lazarus target in glioblastom

   Publicat: 23.09.2022
5. Brain metastases; a SNO consensus review: Part 2

   Publicat: 09.09.2022
6. Brain metastases; a SNO consensus review: Part 1

   Publicat: 26.08.2022
7. Pediatric IDH mutant gliomas

   Publicat: 13.08.2022
8. Low-risk meningioma: Outcomes from NRG 0539

   Publicat: 29.07.2022
9. Selumetinib in children with NF1 and plexiform neurofibroma

   Publicat: 01.07.2022
10. Targeted therapy for BRAF-mutant pediatric glioma

    Publicat: 17.06.2022
11. Early/evolving IDH wild-type glioblastoma

    Publicat: 20.05.2022
12. PI3K signaling in IDH mutant gliomas

    Publicat: 06.05.2022
13. Cell-free DNA from CSF in pediatric, adolescent and young adult patients

    Publicat: 22.04.2022
14. Molecular determinants of neurocognitive deficits in glioma

    Publicat: 08.04.2022
15. H3K27M cell-free tumor DNA tracking in response to ONC201 treatment for diffuse midline glioma

    Publicat: 25.03.2022
16. Clinical trial accrual for women and minorities in neuro-oncology

    Publicat: 11.03.2022
17. The clinical utility of next generation sequencing for IDHwt glioblastoma

    Publicat: 11.02.2022
18. Trabectedin for recurrent grade 2 or 3 meningiomas

    Publicat: 28.01.2022
19. Glioblastoma cell heterogeneity and plasticity

    Publicat: 14.01.2022
20. Moleculary integrated grading for meningioma

    Publicat: 24.12.2021